• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TLAK 细胞起源的蛋白激酶信号通路促进结直肠癌转移。

The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis.

机构信息

The Hormel Institute, University of Minnesota, Austin, MN 55912, USA.

The Hormel Institute, University of Minnesota, Austin, MN 55912, USA; School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, China.

出版信息

EBioMedicine. 2017 Apr;18:73-82. doi: 10.1016/j.ebiom.2017.04.003. Epub 2017 Apr 6.

DOI:10.1016/j.ebiom.2017.04.003
PMID:28412249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5405196/
Abstract

Approximately 90% of all cancer deaths arise from the metastatic dissemination of primary tumors. Metastasis is the most lethal attribute of colorectal cancer. New data regarding the molecules contributing to the metastatic phenotype, the pathways they control and the genes they regulate are very important for understanding the processes of metastasis prognosis and prevention in the clinic. The purpose of this study was to investigate the role of T-LAK cell-originated protein kinase (TOPK) in the promotion of colorectal cancer metastasis. TOPK is highly expressed in human metastatic colorectal cancer tissue compared with malignant adenocarcinoma. We identified p53-related protein kinase (PRPK) as a new substrate of TOPK. TOPK binds with and phosphorylates PRPK at Ser250 in vitro and ex vivo. This site plays a critical role in the function of PRPK. Cell lines stably expressing mutant PRPK (S250A), knockdown TOPK, knockdown PRPK or knockdown of both TOPK and PRPK significantly inhibited liver metastasis of human HCT116 colon cancer cells in a xenograft mouse model. Therefore, we conclude that TOPK directly promotes metastasis of colorectal cancer by modulating PRPK. Thus, these findings may assist in the prediction of prognosis or development of new therapeutic strategies against colon cancer.

摘要

约 90%的癌症死亡是由原发性肿瘤的转移扩散引起的。转移是结直肠癌最致命的特征。关于有助于转移表型的分子、它们控制的途径以及它们调节的基因的新数据,对于理解临床转移预后和预防过程非常重要。本研究旨在探讨 T-LAK 细胞起源蛋白激酶 (TOPK) 在促进结直肠癌转移中的作用。与恶性腺癌相比,TOPK 在人转移性结直肠癌组织中高度表达。我们确定 p53 相关蛋白激酶 (PRPK) 是 TOPK 的一个新底物。TOPK 在体外和体内与 PRPK 结合并在 Ser250 处磷酸化 PRPK。该位点在 PRPK 的功能中起着关键作用。稳定表达突变型 PRPK (S250A)、敲低 TOPK、敲低 PRPK 或同时敲低 TOPK 和 PRPK 的细胞系显著抑制了异种移植小鼠模型中人 HCT116 结肠癌细胞的肝转移。因此,我们得出结论,TOPK 通过调节 PRPK 直接促进结直肠癌的转移。因此,这些发现可能有助于预测结直肠癌的预后或开发新的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/c8cad0dd68b3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/ca7b1003f7a4/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/318fcff938d3/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/bec5637deefa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/363c1e5bbf24/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/9c9cdbdabf98/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/609a68957b40/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/c8cad0dd68b3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/ca7b1003f7a4/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/318fcff938d3/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/bec5637deefa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/363c1e5bbf24/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/9c9cdbdabf98/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/609a68957b40/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c4b/5405196/c8cad0dd68b3/gr5.jpg

相似文献

1
The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis.TLAK 细胞起源的蛋白激酶信号通路促进结直肠癌转移。
EBioMedicine. 2017 Apr;18:73-82. doi: 10.1016/j.ebiom.2017.04.003. Epub 2017 Apr 6.
2
Targeting PRPK Function Blocks Colon Cancer Metastasis.靶向 PRPK 功能块抑制结肠癌转移。
Mol Cancer Ther. 2018 May;17(5):1101-1113. doi: 10.1158/1535-7163.MCT-17-0628. Epub 2018 Feb 26.
3
Targeting PRPK and TOPK for skin cancer prevention and therapy.针对 PRPK 和 TOPK 进行皮肤癌的预防和治疗。
Oncogene. 2018 Oct;37(42):5633-5647. doi: 10.1038/s41388-018-0350-9. Epub 2018 Jun 14.
4
Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon.Src对TOPK的Y74、Y272位点进行磷酸化,可增加TOPK的稳定性并促进结肠癌的发生。
Oncotarget. 2016 Apr 26;7(17):24483-94. doi: 10.18632/oncotarget.8231.
5
Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells.由TOPK-ERK相互作用转导的双向信号增强了HCT116结肠癌细胞的肿瘤发生。
Gastroenterology. 2007 Jul;133(1):219-31. doi: 10.1053/j.gastro.2007.04.048. Epub 2007 Apr 25.
6
Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis.新型选择性 TOPK 抑制剂 SKLB-C05 抑制结直肠癌生长和转移。
Cancer Lett. 2019 Mar 31;445:11-23. doi: 10.1016/j.canlet.2018.12.016. Epub 2018 Dec 24.
7
TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.TOPK/PBK 通过调节 PI3K/PTEN/AKT 通路促进细胞迁移,与肺癌的不良预后相关。
Oncogene. 2012 May 10;31(19):2389-400. doi: 10.1038/onc.2011.419. Epub 2011 Sep 26.
8
Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth.新型 TOPK 抑制剂 HI-TOPK-032 能有效抑制结肠癌生长。
Cancer Res. 2012 Jun 15;72(12):3060-8. doi: 10.1158/0008-5472.CAN-11-3851. Epub 2012 Apr 20.
9
TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.TOPK 通过激活γ-catenin 促进食管鳞癌细胞的转移,通过 Src/GSK3β/STAT3 信号通路。
BMC Cancer. 2019 Dec 30;19(1):1264. doi: 10.1186/s12885-019-6453-z.
10
Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase.泮托拉唑是一种经美国食品药品监督管理局(FDA)批准的质子泵抑制剂,它通过靶向T细胞起源的蛋白激酶来抑制结直肠癌的生长。
Oncotarget. 2016 Apr 19;7(16):22460-73. doi: 10.18632/oncotarget.7984.

引用本文的文献

1
TOPK Inhibition Enhances the Sensitivity of Colorectal Cancer Cells to Radiotherapy by Reducing the DNA Damage Response.TOPK 抑制通过降低 DNA 损伤反应增强结直肠癌细胞对放射治疗的敏感性。
Curr Med Sci. 2024 Jun;44(3):545-553. doi: 10.1007/s11596-024-2884-0. Epub 2024 Jun 20.
2
Identification of 8 candidate microsatellite instability loci in colorectal cancer and validation of the ACVR2A mechanism in the tumor progression.鉴定结直肠癌中的 8 个候选微卫星不稳定性基因座,并验证 ACVR2A 机制在肿瘤进展中的作用。
Sci Rep. 2024 Jun 19;14(1):14145. doi: 10.1038/s41598-024-62753-1.
3
Phosphorylation of PBK at Thr9 by CDK5 correlates with invasion of prolactinomas.

本文引用的文献

1
Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon.Src对TOPK的Y74、Y272位点进行磷酸化,可增加TOPK的稳定性并促进结肠癌的发生。
Oncotarget. 2016 Apr 26;7(17):24483-94. doi: 10.18632/oncotarget.8231.
2
Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase.泮托拉唑是一种经美国食品药品监督管理局(FDA)批准的质子泵抑制剂,它通过靶向T细胞起源的蛋白激酶来抑制结直肠癌的生长。
Oncotarget. 2016 Apr 19;7(16):22460-73. doi: 10.18632/oncotarget.7984.
3
PDZ-binding kinase/T-LAK cell-originated protein kinase is a target of the fucoidan from brown alga Fucus evanescens in the prevention of EGF-induced neoplastic cell transformation and colon cancer growth.
CDK5 对 PBK 的 Thr9 位磷酸化与泌乳素瘤的侵袭相关。
CNS Neurosci Ther. 2024 Feb;30(2):e14629. doi: 10.1111/cns.14629.
4
TP53RK Drives the Progression of Chronic Kidney Disease by Phosphorylating Birc5.TP53RK 通过磷酸化 Birc5 驱动慢性肾脏病的进展。
Adv Sci (Weinh). 2023 Sep;10(25):e2301753. doi: 10.1002/advs.202301753. Epub 2023 Jun 29.
5
FYN/TOPK/HSPB1 axis facilitates the proliferation and metastasis of gastric cancer.FYN/TOPK/HSPB1 轴促进胃癌的增殖和转移。
J Exp Clin Cancer Res. 2023 Apr 4;42(1):80. doi: 10.1186/s13046-023-02652-x.
6
Emerging Role of Plant-Based Dietary Components in Post-Translational Modifications Associated with Colorectal Cancer.植物性膳食成分在与结直肠癌相关的翻译后修饰中的新作用。
Life (Basel). 2023 Jan 18;13(2):264. doi: 10.3390/life13020264.
7
Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC.抑制 ALK-TOPK 信号通路促进 ALK 阳性 NSCLC 细胞凋亡。
Cell Death Dis. 2022 Sep 27;13(9):828. doi: 10.1038/s41419-022-05260-3.
8
MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.MTUS1 是结直肠癌有前途的诊断和预后生物标志物。
World J Surg Oncol. 2022 Aug 13;20(1):257. doi: 10.1186/s12957-022-02702-2.
9
TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC.TOPK/PBK 通过丝氨酸 32 被 ERK2 磷酸化,促进肾癌的肿瘤发生,并与索拉非尼耐药有关。
Cell Death Dis. 2022 May 11;13(5):450. doi: 10.1038/s41419-022-04909-3.
10
The role of T-LAK cell-originated protein kinase in targeted cancer therapy.T-LAK 细胞起源的蛋白激酶在肿瘤靶向治疗中的作用。
Mol Cell Biochem. 2022 Mar;477(3):759-769. doi: 10.1007/s11010-021-04329-5. Epub 2022 Jan 17.
PDZ结合激酶/T-LAK细胞源蛋白激酶是褐藻消失墨角藻岩藻依聚糖预防表皮生长因子诱导的肿瘤细胞转化和结肠癌生长的一个靶点。
Oncotarget. 2016 Apr 5;7(14):18763-73. doi: 10.18632/oncotarget.7708.
4
Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth.新型 TOPK 抑制剂 HI-TOPK-032 能有效抑制结肠癌生长。
Cancer Res. 2012 Jun 15;72(12):3060-8. doi: 10.1158/0008-5472.CAN-11-3851. Epub 2012 Apr 20.
5
Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma.T 细胞淋巴瘤激酶起源蛋白激酶的过表达预示着 I 期肺腺癌患者的预后不良。
Cancer Sci. 2012 Apr;103(4):731-8. doi: 10.1111/j.1349-7006.2011.02197.x. Epub 2012 Feb 3.
6
TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.TOPK/PBK 通过调节 PI3K/PTEN/AKT 通路促进细胞迁移,与肺癌的不良预后相关。
Oncogene. 2012 May 10;31(19):2389-400. doi: 10.1038/onc.2011.419. Epub 2011 Sep 26.
7
T-LAK cell-originated protein kinase (TOPK) phosphorylation of MKP1 protein prevents solar ultraviolet light-induced inflammation through inhibition of the p38 protein signaling pathway.T-LAK 细胞起源的蛋白激酶 (TOPK) 对 MKP1 蛋白的磷酸化通过抑制 p38 蛋白信号通路防止太阳紫外线诱导的炎症。
J Biol Chem. 2011 Aug 26;286(34):29601-9. doi: 10.1074/jbc.M111.225813. Epub 2011 Jun 29.
8
Phosphorylation of H2AX at Ser139 and a new phosphorylation site Ser16 by RSK2 decreases H2AX ubiquitination and inhibits cell transformation.RSK2 对 H2AX 丝氨酸 139 及新磷酸化位点丝氨酸 16 的磷酸化作用降低了 H2AX 的泛素化,并抑制了细胞转化。
Cancer Res. 2011 Jan 15;71(2):393-403. doi: 10.1158/0008-5472.CAN-10-2012. Epub 2011 Jan 11.
9
A chemosensitization screen identifies TP53RK, a kinase that restrains apoptosis after mitotic stress.一项化学增敏筛选发现了 TP53RK,一种在有丝分裂应激后抑制细胞凋亡的激酶。
Cancer Res. 2010 Aug 1;70(15):6325-35. doi: 10.1158/0008-5472.CAN-10-0015. Epub 2010 Jul 20.
10
T-LAK cell-originated protein kinase (TOPK) phosphorylation of Prx1 at Ser-32 prevents UVB-induced apoptosis in RPMI7951 melanoma cells through the regulation of Prx1 peroxidase activity.T-LAK 细胞来源的蛋白激酶 (TOPK) 在丝氨酸 32 位磷酸化 Prx1 可通过调节 Prx1 过氧化物酶活性防止 RPMI7951 黑素瘤细胞中 UVB 诱导的细胞凋亡。
J Biol Chem. 2010 Sep 17;285(38):29138-46. doi: 10.1074/jbc.M110.135905. Epub 2010 Jul 20.